NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 127 filers reported holding NURIX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $259,144 | -13.7% | 32,970 | +9.6% | 0.00% | – |
Q2 2023 | $300,419 | +87.6% | 30,072 | +66.8% | 0.00% | – |
Q1 2023 | $160,115 | -19.1% | 18,031 | 0.0% | 0.00% | – |
Q4 2022 | $197,980 | -15.7% | 18,031 | 0.0% | 0.00% | – |
Q3 2022 | $234,944 | +9.8% | 18,031 | +6.9% | 0.00% | -100.0% |
Q2 2022 | $214,000 | +25.1% | 16,873 | +38.0% | 0.00% | – |
Q1 2022 | $171,000 | -51.7% | 12,226 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $354,000 | -4.3% | 12,226 | -1.1% | 0.00% | 0.0% |
Q3 2021 | $370,000 | +12.8% | 12,358 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $328,000 | +0.9% | 12,358 | +18.4% | 0.00% | 0.0% |
Q1 2021 | $325,000 | – | 10,441 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 4,508,333 | $140,164,000 | 17.73% |
Ponoi II Management, LLC | 686,274 | $21,336,000 | 16.34% |
Column Group LLC | 5,383,333 | $167,368,000 | 16.04% |
Ponoi Management, LLC | 686,274 | $21,336,000 | 12.55% |
Foresite Capital Management IV, LLC | 1,238,456 | $38,504,000 | 4.61% |
Foresite Capital Management V, LLC | 451,522 | $14,038,000 | 4.13% |
WestHill Financial Advisors, Inc. | 283,333 | $8,809,000 | 3.13% |
EcoR1 Capital, LLC | 2,019,019 | $62,771,000 | 2.78% |
Bain Capital Life Sciences Investors, LLC | 1,284,314 | $39,929,000 | 2.26% |
DAFNA Capital Management LLC | 306,320 | $9,523,000 | 2.26% |